Hugel Inc
145020
Company Profile
Business description
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.
Contact
61-20, Sinbuk-ro, Sinbuk-eup
ChuncheonGangwon24206
KORT: +82 332553882
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
625
Stocks News & Analysis
stocks
Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?
Microsoft’s earnings report is expected to touch on AI adoption and monetization.
stocks
World’s largest miner overvalued after solid quarter
The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.
stocks
Hidden value in an expensive ASX
How investors can uncover value beyond the index heavyweights.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,024.20 | 27.20 | -0.30% |
| CAC 40 | 8,233.20 | 76.77 | 0.94% |
| DAX 40 | 24,161.42 | 33.48 | -0.14% |
| Dow JONES (US) | 49,437.14 | 52.89 | -0.11% |
| FTSE 100 | 10,459.68 | 16.78 | -0.16% |
| HKSE | 25,915.20 | 248.04 | -0.95% |
| NASDAQ | 24,557.85 | 99.72 | -0.40% |
| Nikkei 225 | 59,140.23 | 445.63 | -0.75% |
| NZX 50 Index | 12,884.93 | 60.67 | -0.47% |
| S&P 500 | 7,130.65 | 7.25 | -0.10% |
| S&P/ASX 200 | 8,793.40 | 26.10 | -0.30% |
| SSE Composite Index | 4,093.25 | 13.01 | -0.32% |